Hostname: page-component-74656f9884-rngvg Total loading time: 0 Render date: 2026-11-06T00:50:23.762Z Has data issue: false hasContentIssue false

In X. laevis embryos high levels of the anti-apoptotic factor p27BBP/eIF6 are stage-dependently found in BrdU and TUNEL-reactive territories

Published online by Cambridge University Press:  27 July 2010

N. De Marco*
Affiliation:
Department of Structural and Functional Biology, University of Naples Federico II, Naples, Italy.
C. Campanella
Affiliation:
Department of Structural and Functional Biology, University of Naples Federico II, Naples, Italy.
R. Carotenuto
Affiliation:
Department of Structural and Functional Biology, University of Naples Federico II, Naples, Italy.
*
All correspondence to: N. De Marco. Department of Structural and Functional Biology, University of Naples Federico II, Naples, Italy. Tel: +39 081 679189. Fax: +39 081 679233. e-mail: nademarc@unina.it
Rights & Permissions [Opens in a new window]

Summary

p27BBP/eIF6 (β4 binding protein/eukaryotic initiation factor 6) is a highly conserved protein necessary for cell life. In adult eIF6 mice, a 50% decrease in the protein levels in all tissues is accompanied by a reduction in cell proliferation only in the liver, fat cells and cultured fibroblasts. During X. laevis embryogenesis expression of p27BBP/eIF6 is abundant in high proliferative territories. However, in Xenopus cell proliferation appears unaffected following p27BBP/eIF6 over-expression or down-regulation. Indeed, p27BBP/eIF6 is an anti-apoptotic factor acting upstream of Bcl2 that reduces endogenous apoptosis. We studied p27BBP/eIF6 protein localization in wild type embryos and compared it to proliferation and apoptosis. At the beginning of embryogenesis, high levels of p27BBP/eIF6, proliferation and apoptosis overlap. In later development stages high proliferation levels are present in the same regions where higher p27BBP/eIF6 expression is observed, while apoptosis does not appear specifically concentrated in the same sites. The higher presence of p27BBP/eIF6 would appear related to an increased need of apoptosis control in the regions where cell death is essential for normal development.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2010
Figure 0

Figure 1 In toto immunofluorescence with anti-p27BBP/eIF6 antibody of stage 14 embryo, dorsal (a) and lateral (b) view. Staining is relevant in the neural plate (arrow) and in the anteriormost region indicated by the arrowhead. (c) Apoptosis detected by in toto TUNEL assay at stage 14 embryo. A strong signal is present in the neural plate (arrow) with the most intense staining corresponding to the anteriormost portion (arrowhead). (d) immunofluorescence with anti-pH3 antibody. At the early neurula stage numerous mitotic cells are present in the whole embryo. The strongest staining is localized in the developing neuroepithelium (arrow for posteriormost and arrowhead for anteriormost neuroepithelium). (e) In toto immunofluorescence using only secondary antibody BODIPY-conjugates anti-rabbit goat IgG. Staining is absent.

Figure 1

Figure 2 (a) At stage 24, in toto immunofluorescence shows the presence of p27BBP/eIF6 in somites (s), branchial arches (ba) and in the anlagen of optic (e) and otic (otv) vesicles. (b) immunofluorescence with anti-p27BBP/eIF6 antibody on a section of a stage 24 embryo. The protein is abundant in developing brain (arrow) and retina (arrowhead). (c) DAPI staining of section (b). BrdU immunolocalization (d) and TUNEL assay (e) was performed in serial cross-sections of stage 24 embryos. High proliferation rates are present in developing brain (arrow) and eye (arrowhead), while apoptosis levels are reduced compared with earlier stages of neurulation both in brain and in retina (e). Immuno-fluorescence controls using only anti-rabbit goat IgG BODIPY-conjugates as control for anti-p27BBP/eIF6 immunofluorescence (f) and anti-mouse goat IgG BODIPY-conjugates as control for anti-BrdU immunofluorescence (g). Staining is absent.

Figure 2

Figure 3 p27BBP/eIF6 localization in stage 32 embryos. (a) A strong signal is present in somites (s), branchial arches (ba) and developing eye (e). (b) Immunofluorescence on sections shows that p27BBP/eIF6 label is more abundant in dorsal region of the brain (arrow) and in ciliary marginal zone of the eye (arrowhead). (c) DAPI staining of section (b). Immunostaining with anti-BrdU antibody (d) and TUNEL assay (e) on serial sections of a stage 32 embryo show that proliferation and apoptosis are overlapping in the brain. In contrast, in the eye anti-BRDU immunostaining is restricted to CMZ, while TUNEL staining is diffuse in the whole retina. (f) Higher magnification of the brain showed in b. Most anti-p27BBP/eIF6 immunostaining is next to the ventricle in dorsal region of the brain (arrow). (g, h) Details of parts (d) and (e) respectively show that BrdU and TUNEL assays stain the same sites (arrows) strongly labelled by anti-p27BBP/eIF6 antibody. (i) Higher magnification of eye showed in section (b). High levels of p27BBP/eIF6 are present in CMZ (square). (j) detail of section (d) shows a strong localization of mitotic cells in CMZ (square) overlapping with p27BBP/eIF6 immunostaining. (k) detail of section (e) shows that apoptotic cells are diffuse in all developing retina including CMZ. D-V, dorsoventral axis.

Figure 3

Figure 4 p27BBP/eIF6 (a); DAPI staining (b); BrdU immunofluorescence (c); and TUNEL assay (d) in brain of stage 45 embryo. Most p27BBP/eIF6, BrdU and TUNEL signals are close to the brain ventricle (arrow). In the fully laminated retina p27BBP/eIF6 (e) and BrdU (g) staining is restricted to CMZ (arrowhead), whilst the TUNEL signal (h) is present in the whole retina. (f) DAPI staining.